Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779857 · ClinicalTrials.gov registry record · Phase 2
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
A Phase 2 study, sponsored by AtriCure.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00779857 is a Phase 2 study that has completed, run by AtriCure. The registered enrollment target is 70 participants.
The verdict
NCT00779857, a Phase 2 study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
Prospective, non-randomized trial to evaluate the safety and efficacy of the LAA Exclusion Device (Clip) for the exclusion of the LAA via epicardial tissue approximation.
Interventions
- DEVICE AtriCure LAA Exclusion System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00779857
The ClinicalTrials.gov registry entry for NCT00779857 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AtriCure LAA Exclusion System is the first listed.
NCT00779857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00779857 about?
NCT00779857 is a clinical study titled "AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery". Prospective, non-randomized trial to evaluate the safety and efficacy of the LAA Exclusion Device (Clip) for the exclusion of the LAA via epicardial tissue approximation.
What is the current status of trial NCT00779857?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2008-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00779857?
The interventions under investigation include: AtriCure LAA Exclusion System (DEVICE).
Who is sponsoring clinical trial NCT00779857?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.